Role of Vascular Ion Channels in Heart Failure and Cardiovascular Diseases

血管离子通道在心力衰竭和心血管疾病中的作用

基本信息

  • 批准号:
    9762630
  • 负责人:
  • 金额:
    $ 16.43万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-09-01 至 2021-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The proposed K08 Mentored Career Development Award will enable me to develop into an established and independent researcher with expertise on the role of vascular ion channels in heart failure (HF) and other cardiovascular diseases associated with vascular dysfunction, such as hypertension and diabetes. I am a clinical cardiologist, cardiac electrophysiologist, as well as experienced basic and translational researcher whose long-term goal is to understand the electrophysiologic remodeling of the vasculature in cardiovascular diseases to develop new therapies for the treatment of HF and vascular dysfunction. However, further career development and research training is necessary for me to reach this goal. I have a long-standing, productive relationship with my mentor, Dr. Steven Marx, an experienced ion channel researcher, with whom I published the finding that resistance vessels in HF undergo electrical remodeling of the vasculature; specifically, the vascular smooth muscle (VSM) cell membrane potential is depolarized, cytosolic [Ca2+] is elevated, and the expression and activity of vascular large conductance, Ca2+ activated potassium channels (BK channels) are markedly reduced compared to mice without heart failure. I plan to elucidate the ion channels responsible for this vascular dysfunction. The centra hypothesis of this application is that abnormal vascular ion channel activity may be one of the molecular mechanisms that causes vascular dysfunction. I have arranged a multidisciplinary board of established investigators (Dr. Donna Mancini, Dr. Andrew Marks, Dr. Paolo Colombo, Dr. Robert Kass, Dr. Shunichi Homma) and career development mentor (Dr. Jaime Rubin), to help me attain the goals of (1) obtaining comprehensive basic cellular electrophysiologic training, (2) acquiring skills in molecular cardiology to generate and phenotype new mouse models of human congestive heart failure and study possible therapies to reverse vascular dysfunction and heart failure, and (3) conducting ethical research, while acquiring the necessary skills for effective research presentation and publication. I plan to use data and skills acquired during this award to develop new therapies to treat HF and vascular disease.
描述(由申请人提供):拟议的K 08指导职业发展奖将使我能够发展成为一个成熟的和独立的研究人员,具有血管离子通道在心力衰竭(HF)和其他与血管功能障碍相关的心血管疾病(如高血压和糖尿病)中的作用的专业知识。我是一名临床心脏病学家、心脏电生理学家,也是一名经验丰富的基础和转化研究人员,其长期目标是了解心血管疾病中血管系统的电生理重塑,以开发治疗HF和血管功能障碍的新疗法。然而,进一步的职业发展和研究培训是必要的,我达到这一目标。我与我的导师Steven马克思博士有着长期的、富有成效的关系,他是一位经验丰富的离子通道研究人员,我与他一起发表了HF中阻力血管经历血管系统电重构的发现;具体地,血管平滑肌(VSM)细胞膜电位去极化,胞浆[Ca 2 +]升高,血管大电导的表达和活性,与没有心力衰竭的小鼠相比,Ca 2+激活的钾通道(BK通道)显著减少。我计划阐明导致血管功能障碍的离子通道。本申请的中心假设是血管离子通道活性异常可能是导致血管功能障碍的分子机制之一。我已经安排了一个多学科的调查委员会(Donna Mancini博士、Andrew Marks博士、Paolo科隆博博士、Robert Kass博士、Shunichi Homma博士)和职业发展导师(Jaime Rubin博士),帮助我实现以下目标:(1)获得全面的基本细胞电生理学训练,(2)获得分子心脏病学的技能,以产生和表型化人类充血性心力衰竭的新小鼠模型,并研究逆转血管功能障碍和心力衰竭的可能疗法,以及(3)进行伦理研究,同时获得有效的研究报告和出版的必要技能。我计划使用在此期间获得的数据和技能来开发治疗HF和血管疾病的新疗法。

项目成果

期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Matter of Fat: Are Lipids Antiarrhythmic?
脂肪问题:脂质具有抗心律失常作用吗?
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Elaine Y Wan其他文献

Elaine Y Wan的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Elaine Y Wan', 18)}}的其他基金

Understanding the role of mitochondrial dysfunction in cardiac arrhythmias using a novel 3D panoramic optical mapping system
使用新型 3D 全景光学测绘系统了解线粒体功能障碍在心律失常中的作用
  • 批准号:
    10618141
  • 财政年份:
    2020
  • 资助金额:
    $ 16.43万
  • 项目类别:
Understanding the role of mitochondrial dysfunction in cardiac arrhythmias using a novel 3D panoramic optical mapping system
使用新型 3D 全景光学测绘系统了解线粒体功能障碍在心律失常中的作用
  • 批准号:
    10394805
  • 财政年份:
    2020
  • 资助金额:
    $ 16.43万
  • 项目类别:
Elucidating the molecular mechanisms of cognitive decline in atrial fibrillation
阐明房颤认知能力下降的分子机制
  • 批准号:
    9915970
  • 财政年份:
    2019
  • 资助金额:
    $ 16.43万
  • 项目类别:
Role of Vascular Ion Channels in Heart Failure and Cardiovascular Diseases
血管离子通道在心力衰竭和心血管疾病中的作用
  • 批准号:
    9134807
  • 财政年份:
    2015
  • 资助金额:
    $ 16.43万
  • 项目类别:

相似海外基金

A platform for rapidly generating live attenuated enterovirus vaccines
快速生成减毒肠道病毒活疫苗的平台
  • 批准号:
    24K02286
  • 财政年份:
    2024
  • 资助金额:
    $ 16.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
I-Corps: Translation potential of an efficient method to generate live-attenuated and replication-defective DNA viruses for vaccine development
I-Corps:一种有效方法的转化潜力,可生成用于疫苗开发的减毒活病毒和复制缺陷型 DNA 病毒
  • 批准号:
    2420924
  • 财政年份:
    2024
  • 资助金额:
    $ 16.43万
  • 项目类别:
    Standard Grant
Developing a robust native extracellular matrix to improve islet function with attenuated immunogenicity for transplantation
开发强大的天然细胞外基质,以改善胰岛功能,并减弱移植的免疫原性
  • 批准号:
    10596047
  • 财政年份:
    2023
  • 资助金额:
    $ 16.43万
  • 项目类别:
Live attenuated non-transmissible (LANT) Klebsiella pneumoniae vaccines
肺炎克雷伯氏菌减毒非传染性 (LANT) 活疫苗
  • 批准号:
    10742028
  • 财政年份:
    2023
  • 资助金额:
    $ 16.43万
  • 项目类别:
Protecting Pigs From Enzootic Pneumonia: Rational Design Of Safe Attenuated Vaccines.
保护猪免受地方性肺炎:安全减毒疫苗的合理设计。
  • 批准号:
    BB/X017540/1
  • 财政年份:
    2023
  • 资助金额:
    $ 16.43万
  • 项目类别:
    Research Grant
A “Goldilocks” live attenuated poultry vaccine for Infectious Coryza
用于传染性鼻炎的“Goldilocks”家禽减毒活疫苗
  • 批准号:
    LP210301365
  • 财政年份:
    2023
  • 资助金额:
    $ 16.43万
  • 项目类别:
    Linkage Projects
A novel live-attenuated Zika vaccine with a modified 5'UTR
一种带有改良 5UTR 的新型寨卡减毒活疫苗
  • 批准号:
    10730832
  • 财政年份:
    2023
  • 资助金额:
    $ 16.43万
  • 项目类别:
Combating melanoma with an attenuated bacterial therapeutic
用减毒细菌疗法对抗黑色素瘤
  • 批准号:
    10659841
  • 财政年份:
    2023
  • 资助金额:
    $ 16.43万
  • 项目类别:
Investigating Host and Viral Factors for Improved Design of Future Live Attenuated Vaccines for IBV
研究宿主和病毒因素以改进未来 IBV 减毒活疫苗的设计
  • 批准号:
    BB/V016067/1
  • 财政年份:
    2022
  • 资助金额:
    $ 16.43万
  • 项目类别:
    Research Grant
L2M NSERC-Bioengineering attenuated Sclerotinia sclerotiorum strains as bioherbicide for cereal production and lawn management
L2M NSERC-生物工程减毒核盘菌菌株作为谷物生产和草坪管理的生物除草剂
  • 批准号:
    576545-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 16.43万
  • 项目类别:
    Idea to Innovation
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了